1. Home
  2. TEAM vs INSM Comparison

TEAM vs INSM Comparison

Compare TEAM & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEAM
  • INSM
  • Stock Information
  • Founded
  • TEAM 2002
  • INSM 1988
  • Country
  • TEAM Australia
  • INSM United States
  • Employees
  • TEAM N/A
  • INSM N/A
  • Industry
  • TEAM Computer Software: Prepackaged Software
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TEAM Technology
  • INSM Health Care
  • Exchange
  • TEAM Nasdaq
  • INSM Nasdaq
  • Market Cap
  • TEAM 44.6B
  • INSM 41.2B
  • IPO Year
  • TEAM 2015
  • INSM 2000
  • Fundamental
  • Price
  • TEAM $148.38
  • INSM $206.24
  • Analyst Decision
  • TEAM Buy
  • INSM Strong Buy
  • Analyst Count
  • TEAM 26
  • INSM 19
  • Target Price
  • TEAM $251.20
  • INSM $173.35
  • AVG Volume (30 Days)
  • TEAM 3.2M
  • INSM 3.0M
  • Earning Date
  • TEAM 10-30-2025
  • INSM 10-30-2025
  • Dividend Yield
  • TEAM N/A
  • INSM N/A
  • EPS Growth
  • TEAM N/A
  • INSM N/A
  • EPS
  • TEAM N/A
  • INSM N/A
  • Revenue
  • TEAM $5,460,076,000.00
  • INSM $447,022,000.00
  • Revenue This Year
  • TEAM $22.72
  • INSM $40.09
  • Revenue Next Year
  • TEAM $18.72
  • INSM $129.64
  • P/E Ratio
  • TEAM N/A
  • INSM N/A
  • Revenue Growth
  • TEAM 19.51
  • INSM 30.34
  • 52 Week Low
  • TEAM $139.70
  • INSM $60.40
  • 52 Week High
  • TEAM $326.00
  • INSM $209.77
  • Technical
  • Relative Strength Index (RSI)
  • TEAM 42.15
  • INSM 70.57
  • Support Level
  • TEAM $139.70
  • INSM $194.65
  • Resistance Level
  • TEAM $150.89
  • INSM $209.77
  • Average True Range (ATR)
  • TEAM 5.25
  • INSM 6.85
  • MACD
  • TEAM -0.61
  • INSM 0.15
  • Stochastic Oscillator
  • TEAM 34.21
  • INSM 86.77

About TEAM Atlassian Corporation

Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: